ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,173, issued on May 13, was assigned to Queen's University at Kingston (Kingston, Canada).

"Compounds and methods for inhibiting CYP26 enzymes" was invented by Donald Andrew Cameron (Kingston, Canada), Martin Petkovich (Kingston, Canada) and Uttam Saha (Thornhill, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds that are inhibitors of retinoic acid inducible P450 (CYP26) enzymes. The compounds have retinoid activity, are resistant to CYP26-mediated catabolism, act as inhibitors of CYP26B1, and are used for treating diseases that are responsive to retinoids."

The patent was filed on Sept. 13, 2023, under Application No. 18/367,760.

*F...